Recent breakthroughs in the field of obesity treatment have brought a new candidate known as ALLUVI Retatrutide. This compound is a {highlyeffective GLP-1 receptor agonist, designed to mimic the effects of natural glucagon-like peptide-1. Retatrutide has shown impressive results in clinical trials, exhibiting significant losses in body weight and a